Covalys Overview

  • Founded
  • 2002
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Covalys General Information


Developer of tools for protein research. The company provides protein-labeling products. The company's products help researchers in academic institutions, pharmaceutical and biotech companies to improve the efficiency of research into proteins and their function.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
New England Biolabs
Primary Office
  • Benkenstrasse 254
  • 4108 Witterswil
  • Switzerland
+41 061 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Covalys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 28-Nov-2008 00.000 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Mar-2006 00.000 Completed Startup
2. Early Stage VC (Series B) 01-Feb-2005 $2.59M $4.84M Completed Startup
1. Early Stage VC 16-Oct-2003 $2.25M $2.25M Completed Startup
To view Covalys’s complete valuation and funding history, request access »

Covalys Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BV Group Limited Partner Minority 000 0000 000000 0
Daniel Gutenberg Angel (individual) Minority 000 0000 000000 0
Erfindungs Verwertung Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
VI Partners Venture Capital Minority 000 0000 000000 0
To view Covalys’s complete investors history, request access »